We are live on ! Find out more
VMD icon

Viemed Healthcare

127 hedge funds and large institutions have $177M invested in Viemed Healthcare in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 62 increasing their positions, 34 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 34

1.89% more ownership

Funds ownership: 62.89%64.78% (+1.9%)

2% less capital invested

Capital invested by funds: $181M → $177M (-$3.97M)

9% less funds holding

Funds holding: 139127 (-12)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

50% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 22

Holders
127
Holders Change
-12
Holders Change %
-8.63%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
11
Increased
62
Reduced
34
Closed
22
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
XT
76
XTX Topco
Cayman Islands
$150K +$147K +21,680 New
BA
77
BCM Advisors
Louisiana
$147K
Marshall Wace
78
Marshall Wace
United Kingdom
$147K +$144K +21,279 New
MIM
79
MetLife Investment Management
New Jersey
$136K
Mirae Asset Global ETFs Holdings
80
Mirae Asset Global ETFs Holdings
Hong Kong
$136K -$5.82K -858 -4%
GC
81
Globeflex Capital
California
$134K -$128K -18,854 -49%
Invesco
82
Invesco
Georgia
$129K +$25.8K +3,795 +26%
IIM
83
INTECH Investment Management
Florida
$129K +$15.9K +2,349 +14%
CPCM
84
Cardinal Point Capital Management
Ontario, Canada
$128K +$125K +18,480 New
Wells Fargo
85
Wells Fargo
California
$124K +$11K +1,623 +10%
T. Rowe Price Associates
86
T. Rowe Price Associates
Maryland
$117K +$14.5K +2,141 +15%
TWC
87
TD Waterhouse Canada
Ontario, Canada
$100K +$4.93K +726 +5%
Citigroup
88
Citigroup
New York
$90.3K -$87.2K -12,846 -50%
VEA
89
Virtus ETF Advisers
New York
$89.4K +$87.8K +12,939 New
Manulife (Manufacturers Life Insurance)
90
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$88.9K +$2.35K +346 +3%
AllianceBernstein
91
AllianceBernstein
Tennessee
$86.1K +$84.6K +12,460 New
SIP
92
Stoneridge Investment Partners
Pennsylvania
$84K -$13.3K -1,958 -14%
VOYA Investment Management
93
VOYA Investment Management
Georgia
$83.6K +$855 +126 +1%
Millennium Management
94
Millennium Management
New York
$82.5K -$665K -98,018 -89%
Deutsche Bank
95
Deutsche Bank
Germany
$77.6K -$49.5K -7,287 -39%
JF
96
Jump Financial
Illinois
$77.2K -$12.2K -1,802 -14%
State Board of Administration of Florida Retirement System
97
State Board of Administration of Florida Retirement System
Florida
$69.5K
New York State Common Retirement Fund
98
New York State Common Retirement Fund
New York
$51.7K
PFSRSONJ
99
Police & Firemen's Retirement System of New Jersey
New Jersey
$51.3K
TRCT
100
Tower Research Capital (TRC)
New York
$37.7K +$28K +4,122 +309%

VMD Hedge Fund Activity: Q2 2025 in Review

127 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q2 2025, worth a combined $177M — down 2.2% from $181M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VMD and 11 opened new positions — a net loss of 11 holders — while 34 trimmed existing stakes and 62 added.

The largest buyer was BlackRock, adding an estimated $8.2M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $7.35M.

  • 127 institutional investors held Viemed Healthcare (VMD) as of Q2 2025, down from 139 in Q1 2025.
  • Funds reported $177M of Viemed Healthcare stock for Q2 2025, down 2.2% quarter-over-quarter.
  • 11 funds opened new Viemed Healthcare positions in Q2 2025 and 22 closed out, a net change of -11 holders.
  • The largest Viemed Healthcare buyer in Q2 2025 was BlackRock, an estimated $8.2M added.
  • The largest Viemed Healthcare seller in Q2 2025 was Thrivent Financial for Lutherans, an estimated $7.35M sold.

Based on aggregated 13F filings for Q2 2025.